Antispasmodics Drug Market
Antispasmodics Drug Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Antispasmodics Drug Market Size and Growth
The global antispasmodics drug market is projected to grow at a steady rate due to increasing prevalence of gastrointestinal disorders. The market size is estimated to reach $4.2 billion by 2027. Key players in the industry include Allergan, Pfizer, and Mylan, with North America dominating the market share. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Allergan
◍ Hikma Pharmaceutical
◍ Lannett
◍ Mylan
◍ Nexus Pharmaceuticals
◍ Akorn
◍ Aurobindo Pharma
◍ Daiichi Sankyo
◍ Fresenius Kabi
The competitive landscape of the Antispasmodics Drug Market includes companies like Allergan, Hikma Pharmaceutical, Lannett, Mylan, Nexus Pharmaceuticals, Akorn, Aurobindo Pharma, Daiichi Sankyo, Fresenius Kabi, Shanghai Fosun Pharmaceutical, and SunGen Pharma. These companies develop, manufacture, and market antispasmodic drugs to treat conditions such as irritable bowel syndrome and muscle spasms, driving growth in the market.
- Allergan reported sales revenue of $16.09 billion in 2020.
- Hikma Pharmaceutical reported sales revenue of $2.7 billion in 2020.
◍ Shanghai Fosun Pharmaceutical （ Group ）
◍ SunGen Pharma
- Mylan reported sales revenue of $11.5 billion in 2020.
Request Sample Report
Market Segmentation
By Application
Hospital
Homecare
Specialty Clinic
Others
Request Sample Report
By Product
Dicyclomine Hydrochloride
Loperamide Hydrochloride
Others
Market Growth
Request Sample Report
$ X Billion USD
